Zydus Lifesciences Limited (ZYDUSLIFE.BO)
Zydus Lifesciences Limited
Zydus Corporate Park
Scheme No. 63 Survey No. 536, Khoraj (Gandhinagar) Nr. Vaishnodevi Circle, S. G. Highway
Ahmedabad 382481
India
91 79 7180 0000
https://www.zyduslife.com
Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees:
Description
Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally. It operates through Pharmaceuticals and Consumer Products segments. It offers finished dosage human formulations comprising generics, branded generics, and specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients; consumer wellness products; and products in the therapeutic areas of pain management, neurology, metabolic disorder, and liver diseases. The company offers the products under the Everyuth and Nutralite, Complan, Glucon D, and Nycil brands. In addition, the company offers a pipeline of biological products in the areas of oncology, autoimmune disease, nephrology, inflammation, rheumatology, hepatology, and infectious illnesses. Further, it engages in the investment, animal health and veterinary, pharmacy retail, and manpower supply and administration activities. The company was formerly known as Cadila Healthcare Limited and changed its name to Zydus Lifesciences Limited in February 2022. Zydus Lifesciences Limited was founded in 1952 and is headquartered in Ahmedabad, India. Zydus Lifesciences Limited is a subsidiary of Zydus Family Trust.
Corporate Governance
Zydus Lifesciences Limited’s ISS Governance QualityScore as of June 1, 2024 is 5. The pillar scores are Audit: 8; Board: 4; Shareholder Rights: 9; Compensation: 5.
